Weight, Hormones and Metabolic Health: Understanding the Connections

Weight is one of the most emotionally charged topics in medicine, and one of the most misunderstood. For many people, weight gain or difficulty losing weight is not a failure of discipline. It is driven by a complex interplay of hormones, metabolism, genetics, medication, sleep, stress and life circumstances. In this article I explain the medical connections between weight and metabolic health, and the approaches that are genuinely evidence-based.

What we mean by metabolic health

Metabolic health describes how efficiently your body converts food into energy, regulates blood sugar, manages fat storage and maintains cardiovascular function. You can be metabolically unhealthy at any weight, and you can carry extra weight while having a relatively healthy metabolic profile, though higher weight does increase risk over time. The key markers of metabolic health include blood pressure, fasting blood glucose and HbA1c, cholesterol and triglyceride levels, waist circumference, and inflammatory markers.

When several of these markers are abnormal together, it is sometimes called metabolic syndrome, which significantly raises the risk of type 2 diabetes, heart disease and stroke.

How hormones influence weight

Hormones play a central role in how your body stores and uses energy. Several hormonal mechanisms are directly relevant to weight:

• Insulin: produced by the pancreas to regulate blood sugar. When cells become resistant to insulin (insulin resistance), the body produces more, which promotes fat storage, particularly around the abdomen. Insulin resistance can contribute to weight gain and make weight management more difficult in some people. [Flagged for Dr Itunu's clinical review.]
• Oestrogen and progesterone: fluctuations during the menstrual cycle, perimenopause and menopause affect where fat is deposited and how efficiently the body uses energy. The shift from predominantly hip-and-thigh fat storage to abdominal fat during menopause raises cardiovascular and metabolic risk.
• Thyroid hormones: an underactive thyroid (hypothyroidism) slows metabolism and can cause weight gain, fatigue and difficulty losing weight. It is common, treatable and often under-diagnosed.
• Cortisol: chronic stress elevates cortisol, which promotes abdominal fat deposition, increases appetite and disrupts sleep, creating a cycle that is difficult to break without addressing the stress itself.
• Testosterone: in women, raised testosterone (as seen in PCOS) is associated with insulin resistance and central weight gain. In men, low testosterone is linked to increased fat mass and reduced muscle.
• Leptin and ghrelin: these appetite-regulating hormones can become dysregulated with weight gain, sleep deprivation and chronic dieting, making hunger signals unreliable.

PCOS, menopause and weight

PCOS is one of the most common hormonal conditions linked to weight difficulty. Insulin resistance is present in up to 70 per cent of women with PCOS, regardless of their weight. This means even women with a normal BMI can have metabolic complications. Weight management in PCOS needs to address insulin resistance specifically, not just calorie reduction.

During the menopausal transition, falling oestrogen levels contribute to increased abdominal fat, reduced muscle mass and changes in how the body processes carbohydrates. Many women notice a shift in body composition even without eating differently. HRT can help mitigate some of these metabolic changes, particularly when started early in the transition.

Cardiovascular risk and insulin resistance

Insulin resistance is not only a driver of weight gain; it is an independent risk factor for cardiovascular disease. It raises blood pressure, worsens lipid profiles (increasing triglycerides and lowering protective HDL cholesterol), promotes inflammation and accelerates arterial damage. Addressing insulin resistance early, through lifestyle changes and, where appropriate, medication, can significantly reduce long-term cardiovascular risk.

The role of sleep and stress

Sleep and stress are often overlooked in weight management, but they are medically significant. Poor sleep (fewer than seven hours consistently) disrupts leptin and ghrelin, increases cortisol, worsens insulin sensitivity and impairs decision-making around food. Chronic stress has similar metabolic effects, compounded by the emotional eating patterns it often triggers. Any serious approach to metabolic health must address sleep and stress alongside diet and activity.

Psychological wellbeing and weight

The relationship between weight and mental health runs in both directions. Low mood and anxiety can lead to changes in eating patterns and reduced motivation for activity. Equally, weight stigma, repeated failed diets and body dissatisfaction take a significant psychological toll. In my practice I approach weight as a health issue, not a moral one. Compassionate, non-judgmental care produces better outcomes than shame-based approaches, and I always consider the emotional dimension alongside the medical one.

What actually helps: lifestyle

• Nutrition: a balanced, sustainable approach emphasising whole foods, adequate protein, fibre and healthy fats. Lower glycaemic-index choices help manage insulin levels. Extreme restriction and crash diets are counter-productive and often worsen metabolic health.
• Physical activity: a combination of cardiovascular exercise (at least 150 minutes per week of moderate activity) and resistance or strength training (at least twice per week) improves insulin sensitivity, preserves muscle mass and supports cardiovascular health.
• Sleep: prioritising 7 to 9 hours of good-quality sleep, with consistent routines and attention to sleep hygiene.
• Stress management: identifying and addressing chronic stressors, with support where needed.

What actually helps: medication

For some patients, lifestyle changes alone are not enough, and medication can play an important supporting role:

• Metformin: improves insulin sensitivity and is widely used in PCOS and pre-diabetes.
• Incretin-based medicines (such as the GLP-1 receptor agonist semaglutide and the dual GIP/GLP-1 receptor agonist tirzepatide): these newer medications reduce appetite, improve blood sugar control and have demonstrated significant, sustained weight loss in clinical trials. Eligibility is assessed individually according to current NICE and NHS criteria, taking into account BMI, comorbidities, ethnicity and clinical context. They are prescribed alongside lifestyle changes. [Named medicines and prescribing criteria flagged for Dr Itunu's clinical approval.]
• Orlistat: reduces fat absorption. Less commonly used now but remains an option for some patients.
• HRT: in menopausal women, hormone replacement therapy can improve body composition, reduce abdominal fat accumulation and improve insulin sensitivity.

Medication decisions are always individualised. What suits one patient may not suit another, and ongoing monitoring is essential.

“Weight is a medical issue, not a character flaw. When we understand the hormonal and metabolic drivers, we can build a plan that works with your body rather than against it.”

Dr Itunu Johnson

Clinical content flagged for Dr Itunu Johnson's review before publication.

If you would like a thorough assessment of your metabolic health, or support with weight management that looks beyond calories, you can book a consultation or explore my weight and metabolic health service.